HOXA1 and neoplasm: In vivo experiments show that FeS@BSAs have good performance of T1-weighted MR/phototheranostics dual-mode imaging-guided photothermal therapy (PTT) of mouse-bearing 4T1 tumor, demonstrating FeS@BSA to be an efficient T1-weighted MR/PA/PTT theranostic agent.